AI, Welfare & Long-term Care News ・ 🧠 Dementia care
Bioengineer.org · 11/17 23:07 UTC

Researchers have developed an artificial intelligence platform that identified Crassifolin A as an ABCA1 and ABCG1 activator. The compound is described as capable of restoring mitophagy and reducing Alzheimer's pathology in laboratory models.